1
|
Bernal K, Kose O, Leclerc L, Vergnon JM, Pourchez J, Forest V. Development of a protocol of isolation of nanoparticles from patients' broncho-alveolar lavages for their in vitro toxicity assessment. NANOSCALE ADVANCES 2024; 6:458-466. [PMID: 38235099 PMCID: PMC10790975 DOI: 10.1039/d3na00918a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/24/2023] [Accepted: 11/29/2023] [Indexed: 01/19/2024]
Abstract
To investigate potential correlations between human exposure to inhaled particles and pathological effects, the biological monitoring of nanoparticles in broncho-alveolar lavages (BAL) from patients has been proposed. To better understand the underlying mechanisms of toxicity, we propose to couple this biomonitoring of nanoparticles to their in vitro toxicity assessment. However, BAL obtained from regular clinical practice are conditioned with sodium hypochlorite solution (in a 50% v/v ratio), which is toxic to cells. The aim of this study was to develop a protocol to neutralize sodium hypochlorite, allowing to properly investigate the toxicity of the nanoparticles BAL contain. We first tried to neutralize chemically the sodium hypochlorite using H2O2, ascorbic acid or sodium ascorbate but this approach was unsuccessful. In addition, standard toxicology assays (MTT, LDH) could not be used because of interference with neutralizing solutions. We thus changed strategy and used ultracentrifugation to isolate nanoparticles from the sodium hypochlorite solution, with satisfactory extraction yields (88 to 100%). We then incubated the extracted nanoparticles with macrophages from the RAW264.7 cell line and assessed the cell viability and pro-inflammatory response. This study can be used as a proof-of-concept for further study of the biological impact of nanoparticles. This approach paves the way for studies aiming at a better understanding of the aetiology of some idiopathic diseases and underlying mechanisms.
Collapse
Affiliation(s)
- Kévin Bernal
- Mines Saint-Etienne, Univ Jean Monnet, INSERM U 1059 Sainbiose, Centre CIS, CS 62362 42023, 158 cours Fauriel F-42023 Saint-Etienne Cedex 2 France +33477499776
| | - Ozge Kose
- Mines Saint-Etienne, Univ Jean Monnet, INSERM U 1059 Sainbiose, Centre CIS, CS 62362 42023, 158 cours Fauriel F-42023 Saint-Etienne Cedex 2 France +33477499776
| | - Lara Leclerc
- Mines Saint-Etienne, Univ Jean Monnet, INSERM U 1059 Sainbiose, Centre CIS, CS 62362 42023, 158 cours Fauriel F-42023 Saint-Etienne Cedex 2 France +33477499776
| | - Jean-Michel Vergnon
- Univ Lyon, Univ Jean Monnet, INSERM U 1059 Sainbiose F-42023 Saint-Etienne France
- CHU Saint-Etienne, Service de Pneumologie F-42055 Saint-Etienne France
| | - Jérémie Pourchez
- Mines Saint-Etienne, Univ Jean Monnet, INSERM U 1059 Sainbiose, Centre CIS, CS 62362 42023, 158 cours Fauriel F-42023 Saint-Etienne Cedex 2 France +33477499776
| | - Valérie Forest
- Mines Saint-Etienne, Univ Jean Monnet, INSERM U 1059 Sainbiose, Centre CIS, CS 62362 42023, 158 cours Fauriel F-42023 Saint-Etienne Cedex 2 France +33477499776
| |
Collapse
|
3
|
Forest V. Experimental and Computational Nanotoxicology-Complementary Approaches for Nanomaterial Hazard Assessment. NANOMATERIALS 2022; 12:nano12081346. [PMID: 35458054 PMCID: PMC9031966 DOI: 10.3390/nano12081346] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/17/2022] [Revised: 04/07/2022] [Accepted: 04/12/2022] [Indexed: 12/25/2022]
Abstract
The growing development and applications of nanomaterials lead to an increasing release of these materials in the environment. The adverse effects they may elicit on ecosystems or human health are not always fully characterized. Such potential toxicity must be carefully assessed with the underlying mechanisms elucidated. To that purpose, different approaches can be used. First, experimental toxicology consisting of conducting in vitro or in vivo experiments (including clinical studies) can be used to evaluate the nanomaterial hazard. It can rely on variable models (more or less complex), allowing the investigation of different biological endpoints. The respective advantages and limitations of in vitro and in vivo models are discussed as well as some issues associated with experimental nanotoxicology. Perspectives of future developments in the field are also proposed. Second, computational nanotoxicology, i.e., in silico approaches, can be used to predict nanomaterial toxicity. In this context, we describe the general principles, advantages, and limitations especially of quantitative structure–activity relationship (QSAR) models and grouping/read-across approaches. The aim of this review is to provide an overview of these different approaches based on examples and highlight their complementarity.
Collapse
Affiliation(s)
- Valérie Forest
- Mines Saint-Etienne, Univ Lyon, Univ Jean Monnet, Etablissement Français du Sang, INSERM, U1059 Sainbiose, Centre CIS, F-42023 Saint-Etienne, France
| |
Collapse
|
4
|
Camaioni A, Massimiani M, Lacconi V, Magrini A, Salustri A, Sotiriou GA, Singh D, Bitounis D, Bocca B, Pino A, Barone F, Prota V, Iavicoli I, Scimeca M, Bonanno E, Cassee FR, Demokritou P, Pietroiusti A, Campagnolo L. Silica encapsulation of ZnO nanoparticles reduces their toxicity for cumulus cell-oocyte-complex expansion. Part Fibre Toxicol 2021; 18:33. [PMID: 34479598 PMCID: PMC8414698 DOI: 10.1186/s12989-021-00424-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2020] [Accepted: 07/23/2021] [Indexed: 11/23/2022] Open
Abstract
Background Metal oxide nanoparticles (NPs) are increasingly used in many industrial and biomedical applications, hence their impact on occupational and public health has become a concern. In recent years, interest on the effect that exposure to NPs may exert on human reproduction has grown, however data are still scant. In the present work, we investigated whether different metal oxide NPs interfere with mouse cumulus cell-oocyte complex (COC) expansion. Methods Mouse COCs from pre-ovulatory follicles were cultured in vitro in the presence of various concentrations of two types of TiO2 NPs (JRC NM-103 and NM-104) and four types of ZnO NPs (JRC NM-110, NM-111, and in-house prepared uncoated and SiO2-coated NPs) and the organization of a muco-elastic extracellular matrix by cumulus cells during the process named cumulus expansion was investigated. Results We show that COC expansion was not affected by the presence of both types of TiO2 NPs at all tested doses, while ZnO NM-110 and NM-111 induced strong toxicity and inhibited COCs expansion at relatively low concentration. Medium conditioned by these NPs showed lower toxicity, suggesting that, beside ion release, inhibition of COC expansion also depends on NPs per se. To further elucidate this, we compared COC expansion in the presence of uncoated or SiO2-coated NPs. Differently from the uncoated NPs, SiO2-coated NPs underwent slower dissolution, were not internalized by the cells, and showed an overall lower toxicity. Gene expression analysis demonstrated that ZnO NPs, but not SiO2-coated ZnO NPs, affected the expression of genes fundamental for COC expansion. Dosimetry analysis revealed that the delivered-to-cell mass fractions for both NPs was very low. Conclusions Altogether, these results suggest that chemical composition, dissolution, and cell internalization are all responsible for the adverse effects of the tested NPs and support the importance of a tailored, safer-by-design production of NPs to reduce toxicity. Supplementary Information The online version contains supplementary material available at 10.1186/s12989-021-00424-z.
Collapse
Affiliation(s)
- Antonella Camaioni
- Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy
| | - Micol Massimiani
- Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy.,Saint Camillus International University of Health Sciences, Via di Sant'Alessandro, 8, 00131, Rome, Italy
| | - Valentina Lacconi
- Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy
| | - Andrea Magrini
- Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy
| | - Antonietta Salustri
- Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy
| | - Georgios A Sotiriou
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, SE-1, 71 77, Stockholm, Sweden.,Center for Nanotechnology and Nanotoxicology, Department of Environmental Health, T.H. Chan School of Public Health, Harvard University, 655 Huntington Ave, Boston, MA, 02115, USA
| | - Dilpreet Singh
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, SE-1, 71 77, Stockholm, Sweden
| | - Dimitrios Bitounis
- Center for Nanotechnology and Nanotoxicology, Department of Environmental Health, T.H. Chan School of Public Health, Harvard University, 655 Huntington Ave, Boston, MA, 02115, USA
| | - Beatrice Bocca
- Department of Environment and Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy
| | - Anna Pino
- Department of Environment and Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy
| | - Flavia Barone
- Department of Environment and Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy
| | - Valentina Prota
- Department of Environment and Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy
| | - Ivo Iavicoli
- Department of Public Health, Section of Occupational Medicine, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy
| | - Manuel Scimeca
- Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy
| | - Elena Bonanno
- Department of Experimental Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy
| | - Flemming R Cassee
- Department of Inhalation Toxicology, National Institute for Public Health and Environment, 3721, MA, Bilthoven, The Netherlands
| | - Philip Demokritou
- Center for Nanotechnology and Nanotoxicology, Department of Environmental Health, T.H. Chan School of Public Health, Harvard University, 655 Huntington Ave, Boston, MA, 02115, USA
| | - Antonio Pietroiusti
- Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy.,Saint Camillus International University of Health Sciences, Via di Sant'Alessandro, 8, 00131, Rome, Italy
| | - Luisa Campagnolo
- Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy.
| |
Collapse
|
5
|
Forest V, Pourchez J, Pélissier C, Audignon Durand S, Vergnon JM, Fontana L. Relationship between Occupational Exposure to Airborne Nanoparticles, Nanoparticle Lung Burden and Lung Diseases. TOXICS 2021; 9:toxics9090204. [PMID: 34564355 PMCID: PMC8473390 DOI: 10.3390/toxics9090204] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/13/2021] [Revised: 08/23/2021] [Accepted: 08/27/2021] [Indexed: 01/13/2023]
Abstract
The biomonitoring of nanoparticles in patients’ broncho-alveolar lavages (BAL) could allow getting insights into the role of inhaled biopersistent nanoparticles in the etiology/development of some respiratory diseases. Our objective was to investigate the relationship between the biomonitoring of nanoparticles in BAL, interstitial lung diseases and occupational exposure to these particles released unintentionally. We analyzed data from a cohort of 100 patients suffering from lung diseases (NanoPI clinical trial, ClinicalTrials.gov Identifier: NCT02549248) and observed that most of the patients showed a high probability of exposure to airborne unintentionally released nanoparticles (>50%), suggesting a potential role of inhaled nanoparticles in lung physiopathology. Depending on the respiratory disease, the amount of patients likely exposed to unintentionally released nanoparticles was variable (e.g., from 88% for idiopathic pulmonary fibrosis to 54% for sarcoidosis). These findings are consistent with the previously performed mineralogical analyses of BAL samples that suggested (i) a role of titanium nanoparticles in idiopathic pulmonary fibrosis and (ii) a contribution of silica submicron particles to sarcoidosis. Further investigations are necessary to draw firm conclusions but these first results strengthen the array of presumptions on the contribution of some inhaled particles (from nano to submicron size) to some idiopathic lung diseases.
Collapse
Affiliation(s)
- Valérie Forest
- Centre CIS, Mines Saint-Etienne, Univ Lyon, Univ Jean Monnet, INSERM, U1059 Sainbiose, F-42023 Saint-Etienne, France;
- Correspondence:
| | - Jérémie Pourchez
- Centre CIS, Mines Saint-Etienne, Univ Lyon, Univ Jean Monnet, INSERM, U1059 Sainbiose, F-42023 Saint-Etienne, France;
| | - Carole Pélissier
- Department of Occupational Medicine, University Hospital of Saint-Etienne, F-42055 Saint-Etienne, France; (C.P.); (L.F.)
- Univ Lyon, Univ Eiffel, Univ Lyon 1, Univ St Etienne, IFSTTAR, UMRESTTE, UMR_T9405, F-42005 Saint-Etienne, France
| | - Sabyne Audignon Durand
- EPICENE Team, Inserm U1219, Bordeaux Population Health Research Center, University of Bordeaux, F-33076 Bordeaux, France;
- Department of Occupational and Environmental Medicine, Bordeaux Hospital, F-33400 Talence, France
| | - Jean-Michel Vergnon
- Univ Lyon, Univ Jean Monnet, INSERM, U1059 Sainbiose, F-42023 Saint-Etienne, France;
- Department of Chest Diseases and Thoracic Oncology, University Hospital of Saint-Etienne, F-42055 Saint-Etienne, France
| | - Luc Fontana
- Department of Occupational Medicine, University Hospital of Saint-Etienne, F-42055 Saint-Etienne, France; (C.P.); (L.F.)
- Univ Lyon, Univ Eiffel, Univ Lyon 1, Univ St Etienne, IFSTTAR, UMRESTTE, UMR_T9405, F-42005 Saint-Etienne, France
| |
Collapse
|
6
|
Metal Oxide Nanoparticles: Evidence of Adverse Effects on the Male Reproductive System. Int J Mol Sci 2021; 22:ijms22158061. [PMID: 34360825 PMCID: PMC8348343 DOI: 10.3390/ijms22158061] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2021] [Revised: 07/22/2021] [Accepted: 07/23/2021] [Indexed: 12/12/2022] Open
Abstract
Metal oxide nanoparticles (MONPs) are inorganic materials that have become a valuable tool for many industrial sectors, especially in healthcare, due to their versatility, unique intrinsic properties, and relatively inexpensive production cost. As a consequence of their wide applications, human exposure to MONPs has increased dramatically. More recently, their use has become somehow controversial. On one hand, MONPs can interact with cellular macromolecules, which makes them useful platforms for diagnostic and therapeutic interventions. On the other hand, research suggests that these MONPs can cross the blood–testis barrier and accumulate in the testis. Although it has been demonstrated that some MONPs have protective effects on male germ cells, contradictory reports suggest that these nanoparticles compromise male fertility by interfering with spermatogenesis. In fact, in vitro and in vivo studies indicate that exposure to MONPs could induce the overproduction of reactive oxygen species, resulting in oxidative stress, which is the main suggested molecular mechanism that leads to germ cells’ toxicity. The latter results in subsequent damage to proteins, cell membranes, and DNA, which ultimately may lead to the impairment of the male reproductive system. The present manuscript overviews the therapeutic potential of MONPs and their biomedical applications, followed by a critical view of their potential risks in mammalian male fertility, as suggested by recent scientific literature.
Collapse
|